PLEKHG3 Human Pre-designed siRNA Set A contains three designed siRNAs for PLEKHG3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PLEKHG4B Human Pre-designed siRNA Set A contains three designed siRNAs for PLEKHG4B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PLEKHG5 Human Pre-designed siRNA Set A contains three designed siRNAs for PLEKHG5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PLEKHG6 Human Pre-designed siRNA Set A contains three designed siRNAs for PLEKHG6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PLEKHH1 Human Pre-designed siRNA Set A contains three designed siRNAs for PLEKHH1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PLEKHH2 Human Pre-designed siRNA Set A contains three designed siRNAs for PLEKHH2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PLEKHM1 Human Pre-designed siRNA Set A contains three designed siRNAs for PLEKHM1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PLEKHM2 Human Pre-designed siRNA Set A contains three designed siRNAs for PLEKHM2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PLEKHN1 Human Pre-designed siRNA Set A contains three designed siRNAs for PLEKHN1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PLEKHO1 Human Pre-designed siRNA Set A contains three designed siRNAs for PLEKHO1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PLEKHO2 Human Pre-designed siRNA Set A contains three designed siRNAs for PLEKHO2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PLEKHS1 Human Pre-designed siRNA Set A contains three designed siRNAs for PLEKHS1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PLET1 Human Pre-designed siRNA Set A contains three designed siRNAs for PLET1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PLG Human Pre-designed siRNA Set A contains three designed siRNAs for PLG gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PLGRKT Human Pre-designed siRNA Set A contains three designed siRNAs for PLGRKT gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PLIN1 Human Pre-designed siRNA Set A contains three designed siRNAs for PLIN1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PLIN2 Human Pre-designed siRNA Set A contains three designed siRNAs for PLIN2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PLIN3 Human Pre-designed siRNA Set A contains three designed siRNAs for PLIN3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PLIN4 Human Pre-designed siRNA Set A contains three designed siRNAs for PLIN4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PLIN5 Human Pre-designed siRNA Set A contains three designed siRNAs for PLIN5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Plipastatin B1 is a lipopeptide that serves as an inhibitor of phospholipase A2 (PLA2) and possesses antifungal activity[1].

PLX8394 is a potent and selective BRaf inhibitor, with an IC50 of appr 5 nM for BRAFV600E.

PLX8394 is a potent and selective BRaf inhibitor, with an IC50 of appr 5 nM for BRAFV600E.

PLX8394 is a potent and selective BRaf inhibitor, with an IC50 of appr 5 nM for BRAFV600E.

PLX8394 is a potent and selective BRaf inhibitor, with an IC50 of appr 5 nM for BRAFV600E.

PLX8394 is a potent and selective BRaf inhibitor, with an IC50 of appr 5 nM for BRAFV600E.

PLX8394 is a potent and selective BRaf inhibitor, with an IC50 of appr 5 nM for BRAFV600E.

PLK1 Human Pre-designed siRNA Set A contains three designed siRNAs for PLK1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Plk1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Plk1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Plk1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Plk1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

PLK1/BRD4-IN-2 (compound 15) is a BI-2536 (HY-50698) analog and dual inhibitor that targets both Polo-like kinase 1 (PLK1) and BRD4bromodomain (BRD4-BD1 IC50=28 nM, PLK1 IC50=40 nM)[1].

PLK1/BRD4-IN-2 (compound 15) is a BI-2536 (HY-50698) analog and dual inhibitor that targets both Polo-like kinase 1 (PLK1) and BRD4bromodomain (BRD4-BD1 IC50=28 nM, PLK1 IC50=40 nM)[1].

PLK1/BRD4-IN-2 (compound 15) is a BI-2536 (HY-50698) analog and dual inhibitor that targets both Polo-like kinase 1 (PLK1) and BRD4bromodomain (BRD4-BD1 IC50=28 nM, PLK1 IC50=40 nM)[1].

PLK1/BRD4-IN-2 (compound 15) is a BI-2536 (HY-50698) analog and dual inhibitor that targets both Polo-like kinase 1 (PLK1) and BRD4bromodomain (BRD4-BD1 IC50=28 nM, PLK1 IC50=40 nM)[1].

PLK1/BRD4-IN-2 (compound 15) is a BI-2536 (HY-50698) analog and dual inhibitor that targets both Polo-like kinase 1 (PLK1) and BRD4bromodomain (BRD4-BD1 IC50=28 nM, PLK1 IC50=40 nM)[1].

PLK1/BRD4-IN-2 (compound 15) is a BI-2536 (HY-50698) analog and dual inhibitor that targets both Polo-like kinase 1 (PLK1) and BRD4bromodomain (BRD4-BD1 IC50=28 nM, PLK1 IC50=40 nM)[1].

PLK1/BRD4-IN-5 (Compound SC10) is an orally active PLK1 and BRD4 inhibitor with IC50 values of 0.3  nM and 60.8  nM, respectively. PLK1/BRD4-IN-5 can induce MV4-11 cell block in S phase and apoptosis) in a dose-dependent manner. PLK1/BRD4-IN-5 can be used in cancer research[1].

PLK2 Human Pre-designed siRNA Set A contains three designed siRNAs for PLK2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Plk2 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Plk2 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Plk2 Rat Pre-designed siRNA Set A contains three designed siRNAs for Plk2 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

PLK3 Human Pre-designed siRNA Set A contains three designed siRNAs for PLK3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Plk3 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Plk3 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Plk3 Rat Pre-designed siRNA Set A contains three designed siRNAs for Plk3 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

PLK4 Human Pre-designed siRNA Set A contains three designed siRNAs for PLK4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Plk4 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Plk4 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Plk4 Rat Pre-designed siRNA Set A contains three designed siRNAs for Plk4 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.